TAG:
ameripath
Unprecedented Activity Across Lab Medicine
CEO SUMMARY: Laboratory medicine is now considered one of the best opportunities to profit as the demand for healthcare services skyrockets, both in the United States and throughout the world. This is why a flood of investment capital is washing into the laboratory industry. Loaded with c…
Sonic Lands in New York with Sunrise Purchase
CEO SUMMARY: Sonic Healthcare Limited of Sydney, Australia, continues to open its checkbook and purchase independent laboratory companies here in the United States. The latest deal is its agreement to purchase Sunrise Medical Laboratories of Hauppauge, New York, for as much as $168 millio…
DSI Sale Shows Value of Lab Outreach Program
CEO SUMMARY: For other hospital laboratory outreach programs, the pending sale of DSI Laboratories, Inc., of Fort Meyers, Florida, to Laboratory Corporation of America provides useful insights about the market value of these programs. Applying general formulas for determining a sales pric…
Inverness Buys Biosite, Has New Venture with P&G
CEO SUMMARY: On the same day that Inverness Medical Innovations announced that it would acquire Biosite, thus beating out Beckman Coulter in the bidding war for Biosite, Inverness also announced that it had entered into a joint venture with Procter & Gamble. Together, the two companie…
Is There A Power Shift in Pathology?
SINCE THE END OF WORLD WAR II, the dominant practice model for the pathology profession has been the private group practice. Outside of academia and a few other settings, the vast majority of pathologists practiced laboratory medicine as physician-partners in a medical group. During this same period…
Quest Bites: Will Pay $2 Billion for AmeriPath
CEO SUMMARY: From its inception in the mid-1990s as a pathology physician practice management (PPM) company, AmeriPath was a business that its investors created specifically to be sold. Now Quest Diagnostics Incorporated is stepping up to pay a princely ransom of $2 billion to make AmeriP…
New & Stefanelli Launch Anatomic Path Venture
CEO SUMMARY: With little fanfare, Aurora Diagnostics, Inc. opened for business last summer. It states that it has already signed acquisition agreements with five different pathology groups. Former AmeriPath executives James C. New and Martin J. Stefanelli are leading Aurora Diagnostics. H…
October 16, 2006 “Intelligence: Late Breaking Lab News”
American Esoteric Laboratories, Inc. today announced that it has signed an extended, five-year contract to provide reference and esoteric testing services to the 14-hospital Baptist Memorial Health Care Corporation (BMHCC) in Memphis, Tennessee. This relationship was…
September 5, 2006 “Intelligence: Late Breaking Lab News”
On August 14, AmeriPath, Inc. released its second quarter earnings report. Revenues were $191.7 million, an increase of 35% from $143.6 million posted in second quarter of 2005. These numbers reflect the acquisition of Specialty Laboratories, Inc., which AmeriPath ac…
New Lab Firm Life Cycle Demonstrated by Focus
CEO SUMMARY: When an investment group bought Focus Diagnostics, Inc. in 2000, its business objective was to increase the value of the business and sell it between year five and ten of its ownership. Thus, the announcement last Friday that Focus Diagnostics would be acquired by Quest Diagn…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.